Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin Repeat Treatment in IBS-D
NCT01543178Phase 3Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Feb 2012
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of rifaximin in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by Valeant Pharmaceuticals. Started Feb 2012; status: completed.
02
Drugs
rifaximin
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT01543178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01543178.